When Enough Is Not Enough: Screening, Brief Intervention and Referral to Treatment for Hepatitis C in Patients Presenting to the Emergency Department
| dc.contributor.author | Yoder, Lindsay | |
| dc.contributor.author | Vuppalanchi, Raj | |
| dc.contributor.department | Medicine, School of Medicine | en_US |
| dc.date.accessioned | 2018-10-11T13:39:46Z | |
| dc.date.available | 2018-10-11T13:39:46Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Chronic hepatitis C viral (HCV)infection is the most common blood‐borne infection affecting at least 3.5 million people in the USA.1 HCV is a public health threat as it can lead to cirrhosis, liver decompensation with variceal bleeding, ascites, hepatic encephalopathy, hepatocellular carcinoma or death.2 The World Health Organization (WHO) estimates that 399,000 individuals died from cirrhosis or hepatocellular carcinoma caused by HCV infection in 2015. | en_US |
| dc.eprint.version | Author's manuscript | en_US |
| dc.identifier.citation | Yoder, L., & Vuppalanchi, R. (2018). When Enough Is Not Enough: Screening, Brief Intervention and Referral to Treatment for Hepatitis C in Patients Presenting to the Emergency Department. Academic Emergency Medicine, 0(ja). https://doi.org/10.1111/acem.13559 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/17494 | |
| dc.language.iso | en | en_US |
| dc.publisher | Wiley | en_US |
| dc.relation.isversionof | 10.1111/acem.13559 | en_US |
| dc.relation.journal | Academic Emergency Medicine | en_US |
| dc.rights | Publisher Policy | en_US |
| dc.source | Author | en_US |
| dc.subject | Hepatitis C virus | en_US |
| dc.subject | direct-acting antiviral agent | en_US |
| dc.subject | screening | en_US |
| dc.title | When Enough Is Not Enough: Screening, Brief Intervention and Referral to Treatment for Hepatitis C in Patients Presenting to the Emergency Department | en_US |
| dc.type | Article | en_US |